Advisory boards

The Scientific and Ethical advisory Board (SEAB) is an external consultative body which is formed to ensure and improve the scientific performance and the quality of results of PANCAID. The SEAB advises the General Assembly (GA) and the Project Management Office (PMO) upon request, and provides non-binding advice as decision making support. Members of the SEAB are cordially invited to attend the annual GA meetings in order to monitor the progress within each work packages, assess the scientific quality, and to provide critique and feedback, but do not have a right to vote. The SEAB will also consider and mention any ethical issues which may require stronger attention.

The Impact Board (IB) consists of junior and senior members of PANCAID, from academia and industry, as well as patient representatives. The IB is responsible for designing a structured communication plan for dissemination and the exploitation of the project’s results, monitor the steps being taken, and oversee and evaluate the comprehensive internal and external dissemination and societal impact of the project’s results and knowledge gain. In addition, the IB protects PANCAID’s intellectual property rights (IPR).

The Data Safety and Monitoring Board is an internal supervisory body, diligently overseeing and evaluating patient safety and treatment efficacy data throughout the duration of a clinical trial. Additionally, the Board will review issues concerning the safety of the trial participants, data integrity and statistics.

Furthermore, the DSMB is responsible for identifying strengths and weaknesses of the data hub, reviewing the integrity of the data and potential statistical problems, as well as defining of Data privacy and conducting Data Privacy Impact Assessment (DPIA). The DSMB will work to a charter to be set up before the beginning of the study. Following study completion, the DSMB will assist in interpretation of the final results and approve the main study publication.